A290660 Stock Overview
NEOFECT Co., Ltd. develops rehabilitation solutions to help patients with neurological and musculoskeletal injuries.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Neofect Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩903.00 |
| 52 Week High | ₩1,770.00 |
| 52 Week Low | ₩865.00 |
| Beta | 0.90 |
| 11 Month Change | -17.98% |
| 3 Month Change | -28.22% |
| 1 Year Change | -41.70% |
| 33 Year Change | -76.79% |
| 5 Year Change | -85.10% |
| Change since IPO | -88.27% |
Recent News & Updates
Shareholder Returns
| A290660 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -2.7% | -3.9% | 0.2% |
| 1Y | -41.7% | 7.7% | 7.2% |
Return vs Industry: A290660 underperformed the KR Medical Equipment industry which returned 7.7% over the past year.
Return vs Market: A290660 underperformed the KR Market which returned 7.2% over the past year.
Price Volatility
| A290660 volatility | |
|---|---|
| A290660 Average Weekly Movement | 3.2% |
| Medical Equipment Industry Average Movement | 5.7% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 11.1% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A290660's share price has been volatile over the past 3 months.
Volatility Over Time: A290660's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 47 | Ho-young Ban | www.neofect.com |
NEOFECT Co., Ltd. develops rehabilitation solutions to help patients with neurological and musculoskeletal injuries. The company offers Neofect Smart Glove, a device for hand rehab; Neofect Smart Board, a medical device for an upper limb rehabilitation training; Neofect Smart Balance to practice balance and posture during real-world training scenarios; and Neofect Smart Pegboard, a digital pegboard for functional and cognitive rehabilitation. It also provides Neofect ComCog, a cognitive rehabilitation program that helps people with stroke, dementia, traumatic brain injury, brain tumors, and cerebral palsy; NeoMano a robotic glove that enables people with hand paralysis to complete daily activities; and Neofact Connect, a companion App for stroke rehabilitation, as well as orthotic and assistive devices.
Neofect Co.,Ltd Fundamentals Summary
| A290660 fundamental statistics | |
|---|---|
| Market cap | ₩37.36b |
| Earnings (TTM) | -₩4.86b |
| Revenue (TTM) | ₩24.92b |
1.5x
P/S Ratio-7.7x
P/E RatioIs A290660 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A290660 income statement (TTM) | |
|---|---|
| Revenue | ₩24.92b |
| Cost of Revenue | ₩16.53b |
| Gross Profit | ₩8.38b |
| Other Expenses | ₩13.25b |
| Earnings | -₩4.86b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -117.53 |
| Gross Margin | 33.65% |
| Net Profit Margin | -19.51% |
| Debt/Equity Ratio | 71.3% |
How did A290660 perform over the long term?
See historical performance and comparison